Register for upcoming February ACIP meeting
February 21-22, 2018
Deadline for registration:
Non-US Citizens: January 24, 2018
US Citizens: February 5, 2018
Non-US Citizens: January 24, 2018
US Citizens: February 5, 2018
Registration is NOT required to watch the live meeting webcast or to listen via telephone.
On November 9, 2017, FDA approved a new hepatitis B vaccine, HEPLISAV-B, for use in adults 18 years of age and older. HEPLISAV-B is the first licensed vaccine using a CpG adjuvant* and is administered as two doses given one month apart. Further details on this vaccine’s approval can be found at Vaccines Licensed for Use in the United States.
*Cytosine phosphoguanine (CpG) 1018 adjuvant
.png)
No hay comentarios:
Publicar un comentario